HeraMED Limited (HMD.AX)
AUD 0.02
(0.0%)
AUD 0.02
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 402.89 Thousand AUD | 92.21% |
| 2022 | 315.78 Thousand USD | 173.53% |
| 2021 | 115.45 Thousand AUD | 101.14% |
| 2020 | 57.39 Thousand AUD | -72.56% |
| 2019 | 209.21 Thousand AUD | 171.11% |
| 2018 | 77.16 Thousand AUD | 0.0% |
| 2017 | - AUD | 0.0% |
| 2016 | - AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 180.88 Thousand AUD | 0.0% |
| 2023 Q2 | 298.07 Thousand AUD | 0.0% |
| 2023 FY | 606.98 Thousand AUD | 92.21% |
| 2023 Q4 | 308.87 Thousand AUD | 0.0% |
| 2022 Q2 | 194.77 Thousand AUD | 0.0% |
| 2022 Q4 | 117.82 Thousand AUD | 0.0% |
| 2022 FY | 315.78 Thousand USD | 173.53% |
| 2021 FY | 115.45 Thousand AUD | 101.14% |
| 2021 Q4 | 89.45 Thousand AUD | 0.0% |
| 2021 Q2 | 27.5 Thousand AUD | 0.0% |
| 2020 Q4 | 4648.62 AUD | 0.0% |
| 2020 FY | 57.39 Thousand AUD | -72.56% |
| 2020 Q2 | 55.07 Thousand AUD | 0.0% |
| 2019 FY | 209.21 Thousand AUD | 171.11% |
| 2019 Q4 | 83.98 Thousand AUD | 0.0% |
| 2019 Q2 | 124.49 Thousand AUD | 0.0% |
| 2018 Q4 | 51.88 Thousand AUD | 0.0% |
| 2018 FY | 77.16 Thousand AUD | 0.0% |
| 2018 Q2 | 27.33 Thousand AUD | 0.0% |
| 2018 Q1 | 27.33 Thousand AUD | 0.0% |
| 2017 FY | - AUD | 0.0% |
| 2017 Q4 | 27.33 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| 4DMedical Limited | 3.75 Million AUD | 89.268% |
| Adherium Limited | 840.98 Thousand AUD | 52.092% |
| Aroa Biosurgery Limited | 63.35 Million AUD | 99.364% |
| Atomo Diagnostics Limited | 4.08 Million AUD | 90.141% |
| Anteris Technologies Ltd | 4.11 Million AUD | 90.2% |
| Control Bionics Limited | 5.12 Million AUD | 92.142% |
| CardieX Limited | 10.9 Million AUD | 96.306% |
| Compumedics Limited | 49.71 Million AUD | 99.19% |
| Cochlear Limited | 2.25 Billion AUD | 99.982% |
| CleanSpace Holdings Limited | 15.72 Million AUD | 97.437% |
| Cyclopharm Limited | 27.13 Million AUD | 98.515% |
| EMVision Medical Devices Ltd | 11.21 Million AUD | 96.409% |
| Nova Eye Medical Limited | 23.32 Million AUD | 98.273% |
| Imricor Medical Systems, Inc. | 615.56 Thousand AUD | 34.549% |
| ImpediMed Limited | 10.31 Million AUD | 96.096% |
| InhaleRx Limited | 1.2 Million AUD | 66.538% |
| LBT Innovations Limited | 1.25 Million AUD | 67.922% |
| Micro-X Limited | 15.22 Million AUD | 97.353% |
| Neurotech International Limited | 1963.00 AUD | -20424.554% |
| OncoSil Medical Limited | 1.56 Million AUD | 74.262% |
| PolyNovo Limited | 103.19 Million AUD | 99.61% |
| Respiri Limited | 456.91 Thousand AUD | 11.822% |
| SomnoMed Limited | 91.65 Million AUD | 99.56% |
| Universal Biosensors, Inc. | 6.63 Million AUD | 93.926% |
| Uscom Limited | 3.72 Million AUD | 89.189% |
| Visioneering Technologies, Inc. | 8.67 Million AUD | 95.353% |